26 October 2017 EMA/726434/2017 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance: amoxicillin

Procedure no.: PSUSA/00000187/201703

3 0 Churchill P lace ● C anary Wharf ● L ondon E14 5EU ● U nited Kingdom Telephone +4 4 (0 )20 3660 6 000 Facsimile +4 4 (0 )20 3660 5 525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© E uropean M edic ines A genc y, 2 0 1 7 . Reproduc tion is authoris ed provided the s ourc e is ac knowledged.

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number Ospamox 250 mg – lösbare Tabletten Ospamox 250 mg – lösbare Tabletten Ospamox 500 mg – Filmtabletten Ospamox 750 mg – Filmtabletten Ospamox 1000 mg – Filmtabletten Ospamox 125 mg/5 ml Pulver für orale Suspension Ospamox 500 mg/5 ml Pulver für orale Suspension Ospamox 500 mg lösbare Tabletten Ospamox 750 mg lösbare Tabletten Amoxicillin Sandoz 750 mg – Filmtabletten Amoxicillin Sandoz 1000 mg – Filmtabletten Amoxicillin Hexal 500 mg – Filmtabletten Amoxicillin Hexal 750 mg – Filmtabletten Amoxicillin Hexal 1000 mg – Filmtabletten Amoxicillin 1A Pharma 500 mg – Filmtabletten Amoxicillin Sandoz 500 mg – Filmtabletten

8331825

137432

SANDOZ GMBH

AT

8331825

137432

SANDOZ GMBH

AT

922.421

17.659

SANDOZ GMBH

AT

922.420

17.657

SANDOZ GMBH

AT

922.419

17.653

SANDOZ GMBH

AT

AT/H/0116/003

17.661

SANDOZ GMBH

AT

AT/H/0116/005

1-24881

SANDOZ GMBH

AT

NL/H/0455/001

1-25540

SANDOZ GMBH

AT

NL/H/0455/002

1-25541

SANDOZ GMBH

AT

AT/H/0187/002

1-28901

SANDOZ GMBH

AT

AT/H/0187/003

1-28902

SANDOZ GMBH

AT

AT/H/0188/001

1-28778

HEXAL PHARMA GMBH

AT

AT/H/0188/002

1-28779

HEXAL PHARMA GMBH

AT

AT/H/0188/003

1-28780

HEXAL PHARMA GMBH

AT

AT/H/0189/001

1-28793

1A PHARMA GMBH

AT

AT/H/0187/001

1-28900

SANDOZ GMBH

AT

L is t of nationally authorised medicinal products E MA/726434/2017

P age 2 /27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number Amoxicillin 1A Pharma 750 mg - Filmtabletten Amoxicillin 1A Pharma 1000 mg – Filmtabletten C lamoxyl I.V./I.M. 1 g poeder en oplosmiddel voor oplossing voor injectie C LAMOXYL I.V./I.M. 1 g Pulver und Lösungsmittel zur Herstellung einer Injektionslösung C lamoxyl 250 mg/5 ml, poeder voor orale suspensie C lamoxyl 250 mg/5 ml, Pulver zur Herstellung einer Suspension zum Einnehmen C lamoxyl 125 mg/5 ml, poeder voor orale suspensie C lamoxyl 125 mg/5 ml, Pulver zur Herstellung einer Suspension zum Einnehmen C lamoxyl 1 g, dispergeerbare tabletten C lamoxyl 1 g, Tabletten zur Herstellung einer Suspension zum Einnehmen C lamoxyl 500 mg, harde capsules

AT/H/0189/002

1-28794

1A PHARMA GMBH

AT

AT/H/0189/003

1-28795

1A PHARMA GMBH

AT

not available

BE109417

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

BE

not available

BE109417

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

BE

FR/H/600/03/MR

BE080577

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

BE

FR/H/600/03/MR

BE080577

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

BE

FR/H/600/02/MR

BE080595

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

BE

FR/H/600/02/MR

BE080595

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

BE

FR/H/600/01/MR

BE164306

BE

FR/H/0600/001

BE164306

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

UK/H/6220/02

BE191807

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

BE

L is t of nationally authorised medicinal products E MA/726434/2017

BE

P age 3 /27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

BE

number C LAMOXYL 500 mg Kapseln C lamoxyl 250 mg/5 ml, poudre pour suspension buvable C lamoxyl I.V./I.M. 1 g, poudre pour solution injectable/pour perfusion C lamoxyl 125 mg/5 ml, poudre pour suspension buvable C lamoxyl 500 mg, gélules C lamoxyl 1 g, comprimés dispersibles Flemoxin 250 mg/5 ml Pulver zur Herstellung einer Suspension zum Einnehmen Flemoxin Solutab 500 mg lösliche Tabletten Flemoxin Solutab 1 g lösliche Tabletten Flemoxin 250 mg/5 ml poeder voor orale suspensie Flemoxin Solutab 500 mg oplosbare tabletten Flemoxin Solutab 1 g oplosbare tabletten Flemoxin Solutab, comprimés solubles à 1 g Flemoxin Solutab, comprimés solubles à 500 mg

UK/H/6220/02

BE191807

FR/H/600/03/MR

BE080577

BE/H/0259/001

BE109417

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

BE

FR/H/600/02/MR

BE080595

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

BE

UK/H/6220/002

BE191807

BE

FR/H/600/01/MR

BE164306

not available

BE126987

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA GLAXOSMITHKLINE PHARMAC EUTIC ALS SA ASTELLAS PHARMA B.V., OFFIC E BE

not available

BE127005

BE

not available

BE171805

not available

BE126987

ASTELLAS PHARMA B.V., OFFIC E BE ASTELLAS PHARMA B.V., OFFIC E BE ASTELLAS PHARMA B.V., OFFIC E BE

not available

BE127005

B.V.,

BE

not available

BE171805

B.V.,

BE

not available

BE171805

B.V.,

BE

not available

BE127005

ASTELLAS PHARMA OFFIC E BE ASTELLAS PHARMA OFFIC E BE ASTELLAS PHARMA OFFIC E BE ASTELLAS PHARMA OFFIC E BE

B.V.,

BE

L is t of nationally authorised medicinal products E MA/726434/2017

BE

BE BE

BE BE

P age 4 /27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number Flemoxin 250 mg/5 ml poudre pour suspension buvable C lamoxyl I.V./I.M. 1 g poeder en oplosmiddel voor oplossing voor injectie C lamoxyl 250 mg/5 ml, poeder voor orale suspensie C lamoxyl 125 mg/5 ml, poeder voor orale suspensie C lamoxyl 1 g, dispergeerbare tabletten C lamoxyl 500 mg, harde capsules C LAMOXYL 500 mg Kapseln C lamoxyl I.V./I.M. 1 g, poudre pour solution injectable/pour perfusion C lamoxyl 500 mg, gélules C lamoxyl 1 g, comprimés dispersibles Amoxil 500 mg καψάκια, σκληρά Amoxil Forte 250 mg/5 ml κόνις για πόσιμο εναιώρημα Amoxil 500 mg καψάκια, σκληρά

not available

BE126987

ASTELLAS PHARMA B.V., OFFIC E BE

BE

not available

BE109417

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

BE

FR/H/600/03/MR

BE080577

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

BE

FR/H/600/02/MR

BE080595

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

BE

FR/H/600/01/MR

BE164306

BE

UK/H/6220/02

BE191807

UK/H/6220/02

BE191807

BE/H/0259/001

BE109417

GLAXOSMITHKLINE PHARMAC EUTIC ALS GLAXOSMITHKLINE PHARMAC EUTIC ALS GLAXOSMITHKLINE PHARMAC EUTIC ALS GLAXOSMITHKLINE PHARMAC EUTIC ALS

UK/H/6220/002

BE191807

FR/H/600/01/MR

BE164306

UK/H/6220/02

SA SA SA SA

BE BE BE BE

19966

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA GLAXOSMITHKLINE PHARMAC EUTIC ALS SA SMITHKLINE BEEC HAM LTD

FR/H/600/003

3617

SMITHKLINE BEEC HAM LTD

CY

UK/H/6220/02

19966

SMITHKLINE BEEC HAM LTD

CY

L is t of nationally authorised medicinal products E MA/726434/2017

BE CY

P age 5 /27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number Amoxil Forte 250 mg/5 ml κόνις για πόσιμο εναιώρημα Amoxicillin Micro Labs 250 mg Filmtabletten Amoxicillin Micro Labs 250 mg Filmtabletten Amoxicillin Micro Labs 250 mg Filmtabletten Amoxicillin Micro Labs 250 mg Filmtabletten Amoxicillin Micro Labs 250 mg Filmtabletten Amoxicillin Micro Labs 250 mg Filmtabletten Amoxicillin Micro Labs 250 mg Filmtabletten Amoxicillin Micro Labs 250 mg Filmtabletten Amoxicillin Micro Labs 250 mg Filmtabletten Amoxicillin Micro Labs 250 mg Filmtabletten Amoxicillin Micro Labs 250 mg Filmtabletten Amoxicillin Micro Labs 250 mg Filmtabletten Amoxicillin Micro Labs 250 mg Filmtabletten Amoxicillin Micro Labs 250 mg Filmtabletten Amoxicillin Micro Labs 250 mg Filmtabletten

FR/H/600/003

3617

SMITHKLINE BEEC HAM LTD

CY

DE/H/4385/001

94792.00.00

MIC RO LABS GMBH

DE

DE/H/4385/001

94792.00.00

MIC RO LABS GMBH

DE

DE/H/4385/001

94792.00.00

MIC RO LABS GMBH

DE

DE/H/4385/001

94792.00.00

MIC RO LABS GMBH

DE

DE/H/4385/001

94792.00.00

MIC RO LABS GMBH

DE

DE/H/4385/001

94792.00.00

MIC RO LABS GMBH

DE

DE/H/4385/001

94792.00.00

MIC RO LABS GMBH

DE

DE/H/4385/001

94792.00.00

MIC RO LABS GMBH

DE

DE/H/4385/001

94792.00.00

MIC RO LABS GMBH

DE

DE/H/4385/001

94792.00.00

MIC RO LABS GMBH

DE

DE/H/4385/001

94792.00.00

MIC RO LABS GMBH

DE

DE/H/4385/001

94792.00.00

MIC RO LABS GMBH

DE

DE/H/4385/001

94792.00.00

MIC RO LABS GMBH

DE

DE/H/4385/001

94792.00.00

MIC RO LABS GMBH

DE

DE/H/4385/001

94792.00.00

MIC RO LABS GMBH

DE

L is t of nationally authorised medicinal products E MA/726434/2017

P age 6 /27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number Amoxicillin Micro Labs 250 mg Filmtabletten Amoxicillin Micro Labs 250 mg Filmtabletten Amoxicillin Micro Labs 250 mg Filmtabletten Amoxicillin Micro Labs 250 mg Filmtabletten Amoxicillin Micro Labs 500 mg Filmtabletten Amoxicillin Micro Labs 500 mg Filmtabletten Amoxicillin Micro Labs 500 mg Filmtabletten Amoxicillin Micro Labs 500 mg Filmtabletten Amoxicillin Micro Labs 500 mg Filmtabletten Amoxicillin Micro Labs 500 mg Filmtabletten Amoxicillin Micro Labs 500 mg Filmtabletten Amoxicillin Micro Labs 500 mg Filmtabletten Amoxicillin Micro Labs 500 mg Filmtabletten Amoxicillin Micro Labs 500 mg Filmtabletten Amoxicillin Micro Labs 500 mg Filmtabletten Amoxicillin Micro Labs 500 mg Filmtabletten Amoxicillin Micro Labs 500 mg Filmtabletten

DE/H/4385/001

94792.00.00

MIC RO LABS GMBH

DE

DE/H/4385/001

94792.00.00

MIC RO LABS GMBH

DE

DE/H/4385/001

94792.00.00

MIC RO LABS GMBH

DE

DE/H/4385/001

94792.00.00

MIC RO LABS GMBH

DE

DE/H/4385/002

94793.00.00

MIC RO LABS GMBH

DE

DE/H/4385/002

94793.00.00

MIC RO LABS GMBH

DE

DE/H/4385/002

94793.00.00

MIC RO LABS GMBH

DE

DE/H/4385/002

94793.00.00

MIC RO LABS GMBH

DE

DE/H/4385/002

94793.00.00

MIC RO LABS GMBH

DE

DE/H/4385/002

94793.00.00

MIC RO LABS GMBH

DE

DE/H/4385/002

94793.00.00

MIC RO LABS GMBH

DE

DE/H/4385/002

94793.00.00

MIC RO LABS GMBH

DE

DE/H/4385/002

94793.00.00

MIC RO LABS GMBH

DE

DE/H/4385/002

94793.00.00

MIC RO LABS GMBH

DE

DE/H/4385/002

94793.00.00

MIC RO LABS GMBH

DE

DE/H/4385/002

94793.00.00

MIC RO LABS GMBH

DE

DE/H/4385/002

94793.00.00

MIC RO LABS GMBH

DE

L is t of nationally authorised medicinal products E MA/726434/2017

P age 7 /27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number Amoxicillin Micro Labs 500 mg Filmtabletten Amoxicillin Micro Labs 500 mg Filmtabletten Amoxicillin Micro Labs 500 mg Filmtabletten Amoxicillin Micro Labs 500 mg Filmtabletten Amoxicillin Micro Labs 500 mg Filmtabletten Amoxicillin Micro Labs 500 mg Filmtabletten Amoxicillin Micro Labs 750 mg Filmtabletten Amoxicillin Micro Labs 750 mg Filmtabletten Amoxicillin Micro Labs 750 mg Filmtabletten Amoxicillin Micro Labs 750 mg Filmtabletten Amoxicillin Micro Labs 750 mg Filmtabletten Amoxicillin Micro Labs 750 mg Filmtabletten Amoxicillin Micro Labs 750 mg Filmtabletten Amoxicillin Micro Labs 750 mg Filmtabletten Amoxicillin Micro Labs 750 mg Filmtabletten Amoxicillin Micro Labs 750 mg Filmtabletten Amoxicillin Micro Labs 750 mg Filmtabletten

DE/H/4385/002

94793.00.00

MIC RO LABS GMBH

DE

DE/H/4385/002

94793.00.00

MIC RO LABS GMBH

DE

DE/H/4385/002

94793.00.00

MIC RO LABS GMBH

DE

DE/H/4385/002

94793.00.00

MIC RO LABS GMBH

DE

DE/H/4385/002

94793.00.00

MIC RO LABS GMBH

DE

DE/H/4385/002

94793.00.00

MIC RO LABS GMBH

DE

DE/H/4385/003

94794.00.00

MIC RO LABS GMBH

DE

DE/H/4385/003

94794.00.00

MIC RO LABS GMBH

DE

DE/H/4385/003

94794.00.00

MIC RO LABS GMBH

DE

DE/H/4385/003

94794.00.00

MIC RO LABS GMBH

DE

DE/H/4385/003

94794.00.00

MIC RO LABS GMBH

DE

DE/H/4385/003

94794.00.00

MIC RO LABS GMBH

DE

DE/H/4385/003

94794.00.00

MIC RO LABS GMBH

DE

DE/H/4385/003

94794.00.00

MIC RO LABS GMBH

DE

DE/H/4385/003

94794.00.00

MIC RO LABS GMBH

DE

DE/H/4385/003

94794.00.00

MIC RO LABS GMBH

DE

DE/H/4385/003

94794.00.00

MIC RO LABS GMBH

DE

L is t of nationally authorised medicinal products E MA/726434/2017

P age 8 /27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number Amoxicillin Micro Labs 750 mg Filmtabletten Amoxicillin Micro Labs 750 mg Filmtabletten Amoxicillin Micro Labs 750 mg Filmtabletten Amoxicillin Micro Labs 750 mg Filmtabletten Amoxicillin Micro Labs 750 mg Filmtabletten Amoxicillin Micro Labs 750 mg Filmtabletten Amoxicillin Micro Labs 750 mg Filmtabletten Amoxicillin Micro Labs 750 mg Filmtabletten Helicomp® Sandoz®, 20 mg/1000 mg/500 mg magensaftresistente Hartkapseln/Filmtablette n OMEP Plus Amoxicillin + C larithromycin Imacillin, granulat til oral suspension Imacillin, opløselige tabletter Imacillin, opløselige tabletter Imacillin, opløselige tabletter Imacillin, opløselige tabletter Imacillin, opløselige tabletter

DE/H/4385/003

94794.00.00

MIC RO LABS GMBH

DE

DE/H/4385/003

94794.00.00

MIC RO LABS GMBH

DE

DE/H/4385/003

94794.00.00

MIC RO LABS GMBH

DE

DE/H/4385/003

94794.00.00

MIC RO LABS GMBH

DE

DE/H/4385/003

94794.00.00

MIC RO LABS GMBH

DE

DE/H/4385/003

94794.00.00

MIC RO LABS GMBH

DE

DE/H/4385/003

94794.00.00

MIC RO LABS GMBH

DE

DE/H/4385/003

94794.00.00

MIC RO LABS GMBH

DE

not available

63912.00.00

HEXAL AG

DE

not available

65160.00.00

HEXAL AG

DE

not available

11372

MEDA AS

DK

not available

15288

MEDA AS

DK

not available

15289

MEDA AS

DK

not available

15290

MEDA AS

DK

not available

15291

MEDA AS

DK

not available

16713

MEDA AS

DK

L is t of nationally authorised medicinal products E MA/726434/2017

P age 9 /27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number AMITRÓN® 250 mg/5 ml Suspensión extemporánea C lamoxyl 500 mg cápsulas C LAMOXYL 1 g intramuscular C lamoxyl 250 mg polvo para suspensión oral en sobre C lamoxyl 1 g polvo para suspensión oral en sobre C lamoxyl 250 mg/5 ml polvo para suspensión oral en frasco C lamoxyl 1 g comprimidos C lamoxyl 750 mg comprimidos C lamoxyl 500 mg polvo para suspensión oral en sobre AMITRÓN® 500 mg Inyectable AMITRÓN® 1g Inyectable AMITRÓN® 250 mg Inyectable AMITRÓN® 500 mg C ápsulas C lamoxyl 500 mg cápsulas C LAMOXYL 1 g intramuscular

not available

54.625

LDP LABORATORIOS TORLAN, S.A.

ES

not available

50.239

GLAXOSMITHKLINE S.A.

ES

not available

55522

GLAXOSMITHKLINE, S.A.

ES

not available

50.944

GLAXOSMITHKLINE S.A.

ES

not available

59.132

GLAXOSMITHKLINE S.A.

ES

not available

52.015

GLAXOSMITHKLINE S.A.

ES

FR/H/600/01

59.133

GLAXOSMITHKLINE S.A.

ES

not available

51.426

GLAXOSMITHKLINE S.A.

ES

not available

58.840

GLAXOSMITHKLINE S.A.

ES

not available

56.265

ES

not available

56.266

not available

56.264

not available

54.626

not available

50.239

LDP LABORATORIOS TORLAN, S.A. LDP LABORATORIOS TORLAN, S.A. LDP LABORATORIOS TORLAN, S.A. LDP LABORATORIOS TORLAN, S.A. GLAXOSMITHKLINE S.A.

not available

55522

GLAXOSMITHKLINE, S.A.

ES

L is t of nationally authorised medicinal products E MA/726434/2017

ES ES ES ES

P age 10/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number C lamoxyl 250 mg polvo para suspensión oral en sobre C lamoxyl 1 g polvo para suspensión oral en sobre C lamoxyl 1 g comprimidos C lamoxyl 750 mg comprimidos AMOXIC ILLINE SANDOZ 500 mg, gélule HIC ONC IL 500 mg, gélule HIC ONC IL 500 mg, gélule HIC ONC IL 500 mg, gélule HIC ONC IL 500 mg, gélule HIC ONC IL 500 mg, gélule HIC ONC IL 500 mg, gélule HIC ONC IL 125 mg /5 ml, pour poudre suspension buvable HIC ONC IL 250 mg /5 ml, pour poudre suspension buvable HIC ONC IL 500 mg /5 ml, pour poudre suspension buvable C LAMOXYL 1 g, poudre et solvant pour solution injectable (IM)

not available

50.944

GLAXOSMITHKLINE S.A.

ES

not available

59.132

GLAXOSMITHKLINE S.A.

ES

FR/H/600/01

59.133

GLAXOSMITHKLINE S.A.

ES

not available

51.426

GLAXOSMITHKLINE S.A.

ES

NL 21558

34009 367 960 1 0

SANDOZ

FR

not available

316 122-9

BRISTOL-MYERS SQUIBB

FR

not available

316 121-2

BRISTOL-MYERS SQUIBB

FR

not available

316 123-5

BRISTOL-MYERS SQUIBB

FR

not available

553 445-6

BRISTOL-MYERS SQUIBB

FR

not available

554 346-1

BRISTOL-MYERS SQUIBB

FR

not available

342 243-4

BRISTOL-MYERS SQUIBB

FR

not available

3400931703464

BRISTOL-MYERS SQUIBB

FR

not available

3400931761594

BRISTOL-MYERS SQUIBB

FR

not available

3400932026616

BRISTOL-MYERS SQUIBB

FR

not available

VNL11851

LABORATOIRE GLAXOSMITHKLINE

FR

L is t of nationally authorised medicinal products E MA/726434/2017

P age 11/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number C LAMOXYL 2 g, poudre pour solution injectable (IV) C LAMOXYL 500 mg, poudre pour solution injectable (IM, IV) C LAMOXYL 1 g, poudre pour solution injectable (IM - IV) C LAMOXYL 125 mg/5 ml, poudre pour suspension buvable C LAMOXYL 250 mg/5 ml, poudre pour suspension buvable C LAMOXYL 1 g, comprimé dispersible C LAMOXYL 1 g, poudre pour suspension buvable en sachet-dose C LAMOXYL 500 mg/5 ml, poudre pour suspension buvable C LAMOXYL 500 mg, gélule C LAMOXYL 1 g, poudre et solvant pour solution injectable (IM) C LAMOXYL 2 g, poudre pour solution injectable (IV) C LAMOXYL 500 mg, poudre pour solution injectable (IM, IV)

not available

VNL11492

LABORATOIRE GLAXOSMITHKLINE

FR

not available

VNL11494-1

LABORATOIRE GLAXOSMITHKLINE

FR

not available

VNL11491-1

LABORATOIRE GLAXOSMITHKLINE

FR

not available

VNL11074

LABORATOIRE GLAXOSMITHKLINE

FR

not available

VNL11075

LABORATOIRE GLAXOSMITHKLINE

FR

not available

NL15119

FR

not available

NL15559

LABORATOIRE GLAXOSMITHKLINE LABORATOIRE GLAXOSMITHKLINE

not available

VNL11666

LABORATOIRE GLAXOSMITHKLINE

FR

not available

VNL9721

FR

not available

VNL11851

LABORATOIRE GLAXOSMITHKLINE LABORATOIRE GLAXOSMITHKLINE

not available

VNL11492

LABORATOIRE GLAXOSMITHKLINE

FR

not available

VNL11494-1

LABORATOIRE GLAXOSMITHKLINE

FR

L is t of nationally authorised medicinal products E MA/726434/2017

FR

FR

P age 12/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number C LAMOXYL 1 g, poudre pour solution injectable (IM - IV) C LAMOXYL 125 mg/5 ml, poudre pour suspension buvable C LAMOXYL 250 mg/5 ml, poudre pour suspension buvable C LAMOXYL 1 g, comprimé dispersible C LAMOXYL 1 g, poudre pour suspension buvable en sachet-dose C LAMOXYL 500 mg/5 ml, poudre pour suspension buvable C LAMOXYL 500 mg, gélule AMOXIC ILLINE BIOGARAN 500 mg, gélule AMOXIC ILLINE BIOGARAN 500 mg, gélule AMOXIC ILLINE BIOGARAN 500 mg, gélule AMOXIC ILLINE BIOGARAN 500 mg, gélule AMOXIC ILLINE BIOGARAN 500 mg, gélule

not available

VNL11491-1

LABORATOIRE GLAXOSMITHKLINE

FR

not available

VNL11074

LABORATOIRE GLAXOSMITHKLINE

FR

not available

VNL11075

LABORATOIRE GLAXOSMITHKLINE

FR

not available

NL15119

FR

not available

NL15559

LABORATOIRE GLAXOSMITHKLINE LABORATOIRE GLAXOSMITHKLINE

not available

VNL11666

LABORATOIRE GLAXOSMITHKLINE

FR

not available

VNL9721

FR

not available

3400933856731

LABORATOIRE GLAXOSMITHKLINE BIOGARAN

not available

3400933857042

BIOGARAN

FR

not available

3400933856960

BIOGARAN

FR

not available

3400933857103

BIOGARAN

FR

not available

3400933857271

BIOGARAN

FR

L is t of nationally authorised medicinal products E MA/726434/2017

FR

FR

P age 13/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number AMOXIC ILLINE SANDOZ 125 mg/5 ml, poudre pour suspension buvable AMOXIC ILLINE SANDOZ 250 mg/5 ml, poudre pour suspension buvable AMOXIC ILLINE SANDOZ 500 mg, gélule AMOXIC ILLINE RPG 250 mg/5 ml, poudre pour suspension buvable en flacon AMOXIC ILLINE RPG 500 mg/5 ml, poudre pour suspension buvable en flacon Amoxil 500 mg/5 ml κόνις για πόσιμο εναιώρημα AMOXIL AMOXIL Amoxil 250 mg/5 ml κόνις για πόσιμο εναιώρημα Amoxil 1 g κόνις για ενέσιμο διάλυμα ή διάλυμα προς έγχυση AMOXIL AMOXIL Amoxil 250 mg/5 ml κόνις για πόσιμο εναιώρημα Duomox 1000 mg tabletta Duomox 250 mg tabletta

NL 21556

368 829-6

SANDOZ

FR

NL 21557

365 824-3

SANDOZ

FR

NL 21558

34009 367 960 1 0

SANDOZ

FR

not available

NL 21 383

RANBAXY PHARMAC IE GENERIQUES

FR

not available

NL 21 384

RANBAXY PHARMAC IE GENERIQUES

FR

FR/H/600/04/MR

0933603

GLAXOSMITHKLINE AEBE

GR

FR/H/0600/001 UK/H/6220/02 FR/H/600/03/MR

85885/11/16-02-2012 49566/23-06-2014 0933602

GLAXOSMITHKLINE AEBE GLAXOSMITHKLINE AEBE GLAXOSMITHKLINE AEBE

GR GR GR

BE/H/0259/001

0933607

GLAXOSMITHKLINE AEBE

GR

FR/H/0600/001 UK/H/6220/02 FR/H/600/03/MR

85885/11/16-02-2012 49566/23-06-2014 0933602

GLAXOSMITHKLINE AEBE GLAXOSMITHKLINE AEBE GLAXOSMITHKLINE AEBE

GR GR GR

not available

OGYI-T-5460/05

ASTELLAS PHARMA KFT

HU

not available

OGYI-T-5460/01

ASTELLAS PHARMA KFT

HU

L is t of nationally authorised medicinal products E MA/726434/2017

P age 14/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number Duomox 500 mg tabletta Duomox 750 mg tabletta Oramox (Amoxicillin Oral Suspension BP) 125mg / 5ml Oramox (Amoxicillin Oral Suspension BP) 250mg/5ml Oramox 250mg Hard C apsules Oramox 500mg Hard C apsules Amoxil 3g Powder for Oral Suspension Sachets Amoxil Vials 500mg, powder for solution for injection or infusion Amoxil Paediatric 125mg/1.25ml Powder for Oral Suspension Amoxil 3g Powder for Oral Suspension Sachets Amoxil Vials 500mg, powder for solution for injection or infusion Amoxil Paediatric 125mg/1.25ml Powder for Oral Suspension Amoxicillin 250 mg/5 ml powder for oral suspension Amoxicillin 250 mg hard capsules

not available not available not available

OGYI-T-5460/03 OGYI-T-5460/04 PA0298/019/001

ASTELLAS PHARMA KFT ASTELLAS PHARMA KFT ATHLONE LABORATORIES LIMITED

HU HU IE

not available

PA0298/019/002

ATHLONE LABORATORIES LIMITED

IE

not available

PA0298/019/003

IE

not available

PA0298/019/004

UK/H/6220/07

PA 1077/33/6

UK/H/6220/05

PA 1077/33/4

ATHLONE LABORATORIES LIMITED ATHLONE LABORATORIES LIMITED GLAXOSMITHKLINE (IRELAND) LIMITED GLAXOSMITHKLINE (IRELAND) LIMITED

UK/H/6220/03

PA 1077/33/5

GLAXOSMITHKLINE (IRELAND) LIMITED

IE

UK/H/6220/07

PA 1077/33/6

IE

UK/H/6220/05

PA 1077/33/4

GLAXOSMITHKLINE (IRELAND) LIMITED GLAXOSMITHKLINE (IRELAND) LIMITED

UK/H/6220/03

PA 1077/33/5

GLAXOSMITHKLINE (IRELAND) LIMITED

IE

not available

PA0126/282/004

C LONMEL HEALTHC ARE LTD.

IE

not available

PA0126/282/001

C LONMEL HEALTHC ARE LTD.

IE

L is t of nationally authorised medicinal products E MA/726434/2017

IE IE IE

IE

P age 15/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number Amoxicillin 125mg / 5ml powder for oral suspension Amoxicillin 125mg / 5ml powder for oral suspension Amoxicillin 250 mg/5 ml powder for oral suspension Amoxicillin 500 mg hard capsules Amoxicillin 250 mg hard capsules Amoxicillin 500 mg hard capsules Amoxicillin Sandoz 100 mg/ml mixtúruduft, dreifa SINTOPEN “ 250 MG/5 ML GRANULATO PER SOSPENSIONE ORALE” SINTOPEN " 1 G C OMPRESSE" ZIMOX 1 g compresse solubili e masticabili ZIMOX 500 mg capsule rigide ZIMOX 500 mg compresse solubili e masticabili ZIMOX 1 g compresse ZIMOX 250 mg/5 ml polvere per sospensione orale

not available

PA0126/282/003

C LONMEL HEALTHC ARE LTD.

IE

not available

PA0126/282/003

C LONMEL HEALTHC ARE LTD.

IE

not available

PA0126/282/004

C LONMEL HEALTHC ARE LTD.

IE

not available

PA0126/282/002

C LONMEL HEALTHC ARE LTD.

IE

not available

PA0126/282/001

C LONMEL HEALTHC ARE LTD.

IE

not available

PA0126/282/002

C LONMEL HEALTHC ARE LTD.

IE

AT/H/0116/005

IS/1/15/062/01

SANDOZ A/S

IS

not available

023053135

MAGIS FARMAC EUTIC I SRL

IT

not available

023053123

MAGIS FARMAC EUTIC I SRL

IT

not available

023086174

PFIZER ITALIA S.R.L.

IT

not available

023086061

PFIZER ITALIA S.R.L.

IT

not available

023086162

PFIZER ITALIA S.R.L.

IT

not available not available

023086150 023086097

PFIZER ITALIA S.R.L. PFIZER ITALIA S.R.L.

IT IT

L is t of nationally authorised medicinal products E MA/726434/2017

P age 16/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number ZIMOX 100 mg/ml gocce orali, sospensione Amoxina 1 g compresse dispersibili Amoxina 1 g compresse dispersibili Amoxina 250mg/5ml granulato per sospensione orale Amoxina 250mg/5ml granulato per sospensione orale VELAMOX 1 g compresse dispersibili VELAMOX 250 mg/7 ml polvere per sospensione orale VELAMOX 500 mg capsule rigide Amoxil 1 g disperguojamosios tabletės Amoxil 250 mg/5 ml milteliai geriamajai suspensijai Amoxil 1 g disperguojamosios tabletės Amoxil 1 g disperguojamosios tabletės Amoxil 500 mg kietos kapsulės Amoxil 500 mg kietos kapsules

not available

023086186

PFIZER ITALIA S.R.L.

IT

not available

023966094

IT

not available

023966118

not available

023966106

AESC ULAPIUS FARMAC EUTIC I S.R.L. AESC ULAPIUS FARMAC EUTIC I S.R.L. AESC ULAPIUS FARMAC EUTIC I S.R.L.

not available

023966082

AESC ULAPIUS FARMAC EUTIC I S.R.L.

IT

not available

023097102

IT

not available

023097037

MEDIOLANUM FARMAC EUTIC I SPA MEDIOLANUM FARMAC EUTIC I SPA

not available

023097013

IT

FR/H/0600/001

LT/1/04/0031/006

MEDIOLANUM FARMAC EUTIC I SPA BEEC HAM GROUP PLC

FR/H/600/003

LT/1/04/0031/001

BEEC HAM GROUP PLC

LT

FR/H/0600/001

LT/1/04/0031/004

BEEC HAM GROUP PLC

LT

FR/H/0600/001

LT/1/04/0031/005

BEEC HAM GROUP PLC

LT

UK/H/6220/02

LT/1/04/0031/002

BEEC HAM GROUP PLC

LT

UK/H/6220/02

LT/1/04/0031/003

BEEC HAM GROUP PLC

LT

L is t of nationally authorised medicinal products E MA/726434/2017

IT IT

IT

LT

P age 17/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number Amoxil 1 g disperguojamosios tabletės Amoxil 250 mg/5 ml milteliai geriamajai suspensijai Amoxil 1 g disperguojamosios tabletės Amoxil 1 g disperguojamosios tabletės Amoxil 500 mg kietos kapsulės Amoxil 500 mg kietos kapsules C lamoxyl I.V./I.M. 1 g poeder en oplosmiddel voor oplossing voor injectie C LAMOXYL I.V./I.M. 1 g Pulver und Lösungsmittel zur Herstellung einer Injektionslösung C lamoxyl 1 g, dispergeerbare tabletten C lamoxyl 1 g, Tabletten zur Herstellung einer Suspension zum Einnehmen C lamoxyl 500 mg capsules C LAMOXYL 500 mg Kapseln

FR/H/0600/001

LT/1/04/0031/006

BEEC HAM GROUP PLC

LT

FR/H/600/003

LT/1/04/0031/001

BEEC HAM GROUP PLC

LT

FR/H/0600/001

LT/1/04/0031/004

BEEC HAM GROUP PLC

LT

FR/H/0600/001

LT/1/04/0031/005

BEEC HAM GROUP PLC

LT

UK/H/6220/02

LT/1/04/0031/002

BEEC HAM GROUP PLC

LT

UK/H/6220/02

LT/1/04/0031/003

BEEC HAM GROUP PLC

LT

not available

260/08 10 0038

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

LU

not available

260/08 10 0038

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

LU

FR/H/600/01

2008 10 0030

LU

FR/H/0600/001

2008 10 0030

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

not available

260/08 10 0031

LU

not available

260/08 10 0031

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

L is t of nationally authorised medicinal products E MA/726434/2017

LU

LU

P age 18/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number C lamoxyl 125 mg/5 ml, Pulver zur Herstellung einer Suspension zum Einnehmen C lamoxyl 250 mg/5 ml, Pulver zur Herstellung einer Suspension zum Einnehmen C lamoxyl 125 mg/5 ml, poudre pour suspension buvable C lamoxyl 250 mg/5 ml, poudre pour suspension buvable C lamoxyl I.V./I.M. 1 g, poudre pour solution injectable/pour perfusion C lamoxyl 500 mg, gélules C lamoxyl 1 g, comprimés dispersibles C LAMOXYL I.V./I.M. 1 g Pulver und Lösungsmittel zur Herstellung einer Injektionslösung C lamoxyl 500 mg capsules C LAMOXYL 500 mg Kapseln C lamoxyl 125 mg/5 ml, Pulver zur Herstellung einer Suspension zum Einnehmen

FR/H/600/02/MR

0260/08100032

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

LU

FR/H/600/03/MR

0260/08100033

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

LU

FR/H/600/02/MR

0260/08100032

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

LU

FR/H/600/03/MR

0260/08100033

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

LU

BE/H/0259/001

260/08 10 0038

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

LU

not available

260/08 10 0031

LU

FR/H/600/01/MR

2008 10 0030

not available

260/08 10 0038

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA GLAXOSMITHKLINE PHARMAC EUTIC ALS SA GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

not available

260/08 10 0031

LU

not available

260/08 10 0031

FR/H/600/02/MR

0260/08100032

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA GLAXOSMITHKLINE PHARMAC EUTIC ALS SA GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

L is t of nationally authorised medicinal products E MA/726434/2017

LU LU

LU LU

P age 19/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number C lamoxyl 250 mg/5 ml, poudre pour suspension buvable C lamoxyl I.V./I.M. 1 g, poudre pour solution injectable/pour perfusion C lamoxyl 1 g, comprimés dispersibles Flemoxin Solutab, comprimés solubles à 500 mg Flemoxin Solutab, comprimés solubles à 1 g Amoxil 500 mg cietās kapsulas Ospamox 1000 mg apvalkotās tabletes Amoxil 250 mg/5 ml powder for oral suspension Amoxil and associated names 500 mg capsules, hard Amoxil 250 mg/5 ml powder for oral suspension Amoxil and associated names 500 mg capsules, hard IMAC ILLIN® IMAC ILLIN® IMAC ILLIN® IMAC ILLIN® IMAC ILLIN®

FR/H/600/03/MR

0260/08100033

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

LU

BE/H/0259/001

260/08 10 0038

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA

LU

FR/H/600/01/MR

2008 10 0030

LU

not available

BE127005

GLAXOSMITHKLINE PHARMAC EUTIC ALS SA ASTELLAS PHARMA B.V., OFFIC E BE

not available

1996060293

LU

UK/H/6220/02

04-0196

AT/H/0187/003

10-0081

FR/H/600/03/MR

MA447/00105

ASTELLAS PHARMA B.V., OFFIC E BE GLAXOSMITHKLINE LATVIA SIA SANDOZ PHARMAC EUTICALS D.D. BEEC HAM GROUP PLC

UK/H/6220/02

MA447/00103

BEEC HAM GROUP PLC

MT

FR/H/600/03/MR

MA447/00105

BEEC HAM GROUP PLC

MT

UK/H/6220/02

MA447/00103

BEEC HAM GROUP PLC

MT

not not not not not

94-1502 8005 6187 7886 7887

MEDA MEDA MEDA MEDA MEDA

NO NO NO NO NO

available available available available available

L is t of nationally authorised medicinal products E MA/726434/2017

AS AS AS AS AS

LU

LV LV MT

P age 20/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number IMAC ILLIN® IMAC ILLIN® IMAC ILLIN® Ospamox 500 mg, tabletki powlekane Ospamox 750 mg, tabletki powlekane OSPAMOX 1000 MG, 1000 MG, TABLETKI POWLEKANE C lamoxyl 500 mg cápsulas

not available not available not available AT/H/0188/001

7888 7889 7890 16801

MEDA AS MEDA AS MEDA AS SANDOZ GMBH

NO NO NO PL

AT/H/0188/002

16802

SANDOZ GMBH

PL

AT/H/0188/003

16687

SANDOZ GMBH

PL

UK/H/6220/02

4667481

PT

C lamoxyl 500 mg cápsulas

UK/H/6220/02

8352112

C lamoxyl 250 mg/5 ml pó para suspensão oral

FR/H/0600/003

8352203

C lamoxyl 1 g comprimidos dispersíveis

FR/H/600/01/MR

8436816

C lamoxyl 500 mg/5 ml pó para suspensão oral

FR/H/0600/004

8352211

C lamoxyl 1 g comprimidos dispersíveis

FR/H/0600/001

4667580

Flemoxin Flemoxin Flemoxin Flemoxin

not not not not

2234284 4695383 2234482 4695581

BEEC HAM PORTUGUESA, PRODUTOS FARMAC ÊUTIC OS E QUÍMIC OS, LDA BEEC HAM PORTUGUESA, PRODUTOS FARMAC ÊUTIC OS E QUÍMIC OS, LDA SMITH KLINE & FRENC H PORTUGUESA-PRODUTOS FARMAC EUTIC OS LDA SMITH KLINE & FRENC H PORTUGUESA-PRODUTOS FARMAC EUTIC OS LDA SMITH KLINE & FRENC H PORTUGUESA-PRODUTOS FARMAC EUTIC OS LDA SMITH KLINE & FRENC H PORTUGUESA-PRODUTOS FARMAC EUTIC OS LDA ASTELLAS FARMA LDA. ASTELLAS FARMA LDA. ASTELLAS FARMA LDA. ASTELLAS FARMA LDA.

Solutab® Solutab® Solutab® Solutab®

available available available available

L is t of nationally authorised medicinal products E MA/726434/2017

PT

PT PT PT PT PT PT PT PT

P age 21/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised PT

number C lamoxyl 500 mg cápsulas

UK/H/6220/02

4667481

C lamoxyl 500 mg cápsulas

UK/H/6220/02

8352112

C lamoxyl 250 mg/5 ml pó para suspensão oral

FR/H/0600/003

8352203

C lamoxyl 1 g comprimidos dispersíveis

FR/H/600/01/MR

8436816

C lamoxyl 500 mg/5 ml pó para suspensão oral

FR/H/0600/004

8352211

C lamoxyl 1 g comprimidos dispersíveis

FR/H/0600/001

4667580

OSPAMOX 125 MG/5 ML

AT/H/0116/003

5022082

AMOXIC ILINA SANDOZ 1000 mg comprimate filmate AMOXIC ILINA SANDOZ 500 mg comprimate filmate AMOXIC ILINA SANDOZ 500 mg comprimate filmate AMOXIC ILINA SANDOZ 500 mg comprimate filmate

AT/H/0187/003

5475/2013/08

BEEC HAM PORTUGUESA, PRODUTOS FARMAC ÊUTIC OS E QUÍMIC OS, LDA BEEC HAM PORTUGUESA, PRODUTOS FARMAC ÊUTIC OS E QUÍMIC OS, LDA SMITH KLINE & FRENC H PORTUGUESA-PRODUTOS FARMAC EUTIC OS LDA SMITH KLINE & FRENC H PORTUGUESA-PRODUTOS FARMAC EUTIC OS LDA SMITH KLINE & FRENC H PORTUGUESA-PRODUTOS FARMAC EUTIC OS LDA SMITH KLINE & FRENC H PORTUGUESA-PRODUTOS FARMAC EUTIC OS LDA SANDOZ FARMAC ÊUTIC A LDA. S.C . SANDOZ S.R.L.

AT/H/0187/001

5474/2013/01

S.C . SANDOZ S.R.L.

RO

AT/H/0187/001

5474/2013/02

S.C . SANDOZ S.R.L.

RO

AT/H/0187/001

5474/2013/04

S.C . SANDOZ S.R.L.

RO

L is t of nationally authorised medicinal products E MA/726434/2017

PT

PT PT PT PT PT RO

P age 22/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number AMOXIC ILINA SANDOZ 500 mg comprimate filmate AMOXIC ILINA SANDOZ 500 mg comprimate filmate AMOXIC ILINA SANDOZ 500 mg comprimate filmate AMOXIC ILINA SANDOZ 500 mg comprimate filmate AMOXIC ILINA SANDOZ 500 mg comprimate filmate AMOXIC ILINA SANDOZ 500 mg comprimate filmate AMOXIC ILINA SANDOZ 500 mg comprimate filmate AMOXIC ILINA SANDOZ 1000 mg comprimate filmate AMOXIC ILINA SANDOZ 1000 mg comprimate filmate AMOXIC ILINA SANDOZ 1000 mg comprimate filmate AMOXIC ILINA SANDOZ 1000 mg comprimate filmate

AT/H/0187/001

5474/2013/03

S.C . SANDOZ S.R.L.

RO

AT/H/0187/001

5474/2013/05

S.C . SANDOZ S.R.L.

RO

AT/H/0187/001

5474/2013/06

S.C . SANDOZ S.R.L.

RO

AT/H/0187/001

5474/2013/07

S.C . SANDOZ S.R.L.

RO

AT/H/0187/001

5474/2013/09

S.C . SANDOZ S.R.L.

RO

AT/H/0187/001

5474/2013/08

S.C . SANDOZ S.R.L.

RO

AT/H/0187/001

5474/2013/10

S.C . SANDOZ S.R.L.

RO

AT/H/0187/003

5475/2013/01

S.C . SANDOZ S.R.L.

RO

AT/H/0187/003

5475/2013/02

S.C . SANDOZ S.R.L.

RO

AT/H/0187/003

5475/2013/04

S.C . SANDOZ S.R.L.

RO

AT/H/0187/003

5475/2013/03

S.C . SANDOZ S.R.L.

RO

L is t of nationally authorised medicinal products E MA/726434/2017

P age 23/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number AMOXIC ILINA SANDOZ 1000 mg comprimate filmate AMOXIC ILINA SANDOZ 1000 mg comprimate filmate AMOXIC ILINA SANDOZ 1000 mg comprimate filmate AMOXIC ILINA SANDOZ 1000 mg comprimate filmate AMOXIC ILINA SANDOZ 1000 mg comprimate filmate Amimox 375 mg filmdragerade tabletter Amimox 500 mg filmdragerade tabletter Imacillin 750 mg tabletter Amimox 750 mg filmdragerade tabletter Amimox 50 mg/ml granulat till oral suspension Imacillin 1 g tabletter Amimox 100 mg/ml granulat till oral suspension Amimox 125 mg granulat till oral suspension, dospåse Duomox 1 000 Duomox 125

AT/H/0187/003

5475/2013/05

S.C . SANDOZ S.R.L.

RO

AT/H/0187/003

5475/2013/06

S.C . SANDOZ S.R.L.

RO

AT/H/0187/003

5475/2013/07

S.C . SANDOZ S.R.L.

RO

AT/H/0187/003

5475/2013/10

S.C . SANDOZ S.R.L.

RO

AT/H/0187/003

5475/2013/09

S.C . SANDOZ S.R.L.

RO

not available

11538

MEDA AB

SE

not available

11647

MEDA AB

SE

not available

11801

MEDA AB

SE

not available

11539

MEDA AB

SE

not available

11541

MEDA AB

SE

not available not available

11802 11837

MEDA AB MEDA AB

SE SE

not available

11540

MEDA AB

SE

not available not available

15/0383/95-S 15/0383/95-S

ASTELLAS PHARMA S.R.O. ASTELLAS PHARMA S.R.O.

SK SK

L is t of nationally authorised medicinal products E MA/726434/2017

P age 24/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number Duomox 250 Duomox 375 Duomox 750 Duomox 500 Amoxicillin 125mg/5ml Oral Suspension Sugar Free Amoxicillin 250mg/5ml Oral Suspension Sugar Free Amoxicillin 125mg/5ml Oral Suspension Sugar Free Amoxicillin 250mg/5ml Oral Suspension Sugar Free Amoxicillin 500 mg C apsules Amoxicillin Oral Suspension BP 250 mg/5 ml Amoxicillin 250 mg C apsules Amoxicillin Sugar Free Suspension BP 125mg/5ml Amoxicillin Sugar Free Suspension BP 250mg/5ml Amoxil C apsules 250 mg Amoxil C apsules 500 mg Amoxil Vials for Injection 1g

not not not not not

available available available available available

15/0383/95-S 15/0383/95-S 15/0383/95-S 15/0383/95-S PL 30464/0088

ASTELLAS PHARMA S.R.O. ASTELLAS PHARMA S.R.O. ASTELLAS PHARMA S.R.O. ASTELLAS PHARMA S.R.O. ATHLONE PHARMAC EUTIC ALS LIMITED

SK SK SK SK UK

not available

PL 30464/0089

ATHLONE PHARMAC EUTIC ALS LIMITED

UK

not available

PL 30464/0090

ATHLONE PHARMAC EUTIC ALS LIMITED

UK

not available

PL 30464/0091

ATHLONE PHARMAC EUTIC ALS LIMITED

UK

not available

PL 30464/0106

UK

not available

PL 30464/0010

ATHLONE PHARMAC EUTIC ALS LIMITED ATHLONE PHARMAC EUTIC ALS LIMITED

not available

PL 30464/0105

UK

not available

PL 21880/0123

ATHLONE PHARMAC EUTIC ALS LIMITED MEDREIC H PLC

not available

PL 21880/0124

MEDREIC H PLC

UK

UK/H/6220/01 UK/H/6220/02 UK/H/6220/06

PL 00038/0103 PL 00038/0105 PL 00038/0225

BEEC HAM GROUP PLC BEEC HAM GROUP PLC BEEC HAM GROUP PLC

UK UK UK

L is t of nationally authorised medicinal products E MA/726434/2017

UK

UK

P age 25/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number Amoxil Sachets 3 G Sucrose-Free Amoxil Paediatric Suspension Amoxil Vials for Injection 250 mg Amoxil Vials for Injection 500 mg Amoxil C apsules 250 mg Amoxil C apsules 500 mg Amoxil Vials for Injection 1g Amoxil Sachets 3 G Sucrose-Free Amoxil Paediatric Suspension Amoxil Vials for Injection 250 mg Amoxil Vials for Injection 500 mg Amoxicillin 250mg C apsules Amoxicillin 500mg C apsules Amoxicillin 250 mg/5 ml powder for oral suspension Amoxicillin 500 mg hard capsules Amoxicillin 250 mg hard capsules Amoxicillin 125mg/5ml Suspension

UK/H/6220/07

PL 00038/0334

BEEC HAM GROUP PLC

UK

UK/H/6220/03

PL 00038/0107

BEEC HAM GROUP PLC

UK

UK/H/6220/04

0038/0221

BEEC HAM GROUP PLC

UK

UK/H/6220/05

PL 00038/0222

BEEC HAM GROUP PLC

UK

UK/H/6220/01 UK/H/6220/02 UK/H/6220/06

PL 00038/0103 PL 00038/0105 PL 00038/0225

BEEC HAM GROUP PLC BEEC HAM GROUP PLC BEEC HAM GROUP PLC

UK UK UK

UK/H/6220/07

PL 00038/0334

BEEC HAM GROUP PLC

UK

UK/H/6220/03

PL 00038/0107

BEEC HAM GROUP PLC

UK

UK/H/6220/04

0038/0221

BEEC HAM GROUP PLC

UK

UK/H/6220/05

PL 00038/0222

BEEC HAM GROUP PLC

UK

not available

PL 36722/0019

UK

not available

PL 36722/0020

AT/H/0116/004

PL 04416/0485

SPEC IAL C ONC EPT DEVELOPMENT (UK) LTD SPEC IAL C ONC EPT DEVELOPMENT (UK) LTD SANDOZ LTD

AT/H/0116/002

PL 04416/0577

SANDOZ LTD

UK

AT/H/0116/001

PL 04416/0576

SANDOZ LTD

UK

AT/H/0116/003

PL 04416/0484

SANDOZ LTD

UK

L is t of nationally authorised medicinal products E MA/726434/2017

UK UK

P age 26/27

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

Member State

product is authorised

number Amoxicillin Mixture BP 125mg/5ml Amoxicillin Mixture BP 250mg/5ml Amoxicillin 250mg C apsules Amoxicillin 500mg C apsules Amoxicillin 500 mg C apsules Amoxicillin 250 mg C apsules Amoxicillin 500 mg C apsules

not available

PL 06464/1420

WAYMADE PLC

UK

not available

PL 06464/1421

WAYMADE PLC

UK

not available

PL 06464/1418

WAYMADE PLC

UK

not available

PL 06464/1419

WAYMADE PLC

UK

not available

PL 44041/0002

NOUMED LIFE SC IENC ES

UK

not available

PL 40496/0041

BRILL PHARMA LIMITED

UK

not available

PL 40496/0042

BRILL PHARMA LIMITED

UK

L is t of nationally authorised medicinal products E MA/726434/2017

P age 27/27

PSUSA/00000187/201703 - European Medicines Agency - Europa EU

Oct 26, 2017 - Flemoxin 250 mg/5 ml. Pulver zur Herstellung einer Suspension zum. Einnehmen not available. BE126987. ASTELLAS PHARMA B.V.,. OFFICE BE. BE ..... 365 824-3. SANDOZ. FR. AMOXICILLINE SANDOZ. 500 mg, gélule. NL 21558. 34009 367 960 1 0. SANDOZ. FR. AMOXICILLINE RPG 250 mg/5 ml ...

313KB Sizes 55 Downloads 332 Views

Recommend Documents

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Eleclazine - European Medicines Agency - Europa EU
Feb 9, 2017 - Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply).

July 2017 - European Medicines Agency - Europa EU
Jul 5, 2017 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

SME Office - European Medicines Agency - Europa EU
maximises the chances of a successful marketing authorisation. ... marketing authorisation. • inclusion in the public SME ... E-mail [email protected]. Website ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Action plan - European Medicines Agency - Europa EU
5 days ago - Guidelines should include more details on the principles of good information design in which content and layout are ... relevance and importance of the QRD template is also acknowledged in this respect as it is the main tool .... databas

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - Add an existing Tag to a specific Term . ...... This service creates an email body (text/html) of a user's notification data, a notification is based on.

ATMP - European Medicines Agency - Europa EU
Nov 24, 2017 - E8. 09/08/2017. 10/08/2017. 24/08/2017 17/08/2017 22/08/2017. 24/08/2017. 30/08/2017. 01/09/2017. 04/09/2017. 08/09/2017. 14/09/2017.

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Evofosfamide - European Medicines Agency - Europa EU
Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply). (possible) lack of ...

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

minoxidil - European Medicines Agency - Europa EU
Jun 14, 2018 - Page 2/26. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the.

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för

latanoprost - European Medicines Agency - Europa EU
May 13, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ..... Xaloptic Free. NL/H/3193/001.

Cyproterone/ethinylestradiol - European Medicines Agency - Europa EU
March 2016 a joint database drug utilisation final study report to the European .... With regards to prescription of CPA/EE for contraceptive management, ...

ganciclovir - European Medicines Agency - Europa EU
Feb 9, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. 20010180.

July 2016 - European Medicines Agency - Europa EU
For a list of RSS readers please refer to our RSS guide and follow the instructions ..... PCWP and HCPWP joint meeting: Workshop on social media - Sep 2016.

Stem cell - European Medicines Agency - Europa EU
Jul 14, 2016 - Stem cell-based products for veterinary use: specific ... potentially delay time to rejection providing a window of therapeutic benefit but limiting ...